Business Context and Reporting Period
Company: Organogenesis Holdings Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 12, 2019 (Earliest Event Reported)
Key Event Date: March 14, 2019
The Company entered into a new Credit Agreement and terminated prior financing arrangements. Additionally, the Company's warrants were formally delisted from The Nasdaq Stock Market.
Key Financial Metrics and Debt Structure
New Debt Facility (Credit Agreement):
- Total Aggregate Principal: $100,000,000
- Term Loan Facility:
- Tranche 1: $40,000,000 (Funded March 14, 2019).
- Tranche 2: $10,000,000 (Available until Sept 30, 2019, subject to revenue and EBITDA milestones).
- Tranche 3: $10,000,000 (Available until March 31, 2020; increases to $20,000,000 if Tranche 2 milestones are not met).
- Interest Rate: WSJ Prime Rate + 3.75%.
- Repayment: Interest-only through March 14, 2021; 36 equal monthly principal installments thereafter.
- Maturity: March 14, 2024.
- Final Payment: Includes a fee equal to 6.25% of the original aggregate principal amount.
- Revolving Facility:
- Capacity: Lesser of $40,000,000 or the Borrowing Base.
- Interest Rate: WSJ Prime Rate.
- Fees: Minimum interest requirement (25% of commitments), unused line fee (0.25% per annum), and facility fees ($500,000 upfront + $100,000 annually).
- Maturity: March 14, 2024.
Termination of Prior Obligations:
- Prior Credit Facility: Terminated with no early termination penalties.
- Eastward Master Lease: Terminated with a final payment (including penalty) of $17,648,951.71.
Covenants and Liquidity:
- Revenue Covenants: Minimum trailing twelve-month revenue required to reach $231,500,000 by December 31, 2019.
- Liquidity Covenant: Must maintain the greater of 6 months of Monthly Burn or $10,000,000.
- Collateral: Secured by substantially all assets, including intellectual property.
Material Changes Versus Prior Period
- Debt Restructuring: Replaced the 2017 Credit Agreement with a larger $100 million facility featuring milestone-based tranches and a significant final payment fee (6.25%).
- Lease Termination: Paid approximately $17.65 million to terminate the Eastward Master Lease, replacing it with a requirement to enter into new lease agreements by December 31, 2019.
- Related Party Transaction: Landlords (controlled by board members and majority stockholders) subordinated their rent claims to the new lenders.
- Delisting: Company warrants were delisted from Nasdaq due to failure to meet the 400 round lot holder requirement.
Outlook, Risks, and Contingencies
- Performance Milestones: Access to $20 million of the Term Loan (Tranches 2 and 3) is contingent on achieving specific revenue targets ($221.25 million TTM) and limiting EBITDA losses ($5 million) by September 2019.
- Prepayment Penalties: Significant prepayment premiums apply (3% in year 1, 2% in year 2, 1% in year 3).
- Restrictive Covenants: The agreement restricts dividends, stock repurchases, additional indebtedness, and asset dispositions.
- Lease Obligation: The Company must secure new long-term lease agreements for its Canton, MA facilities by year-end 2019.
Investor Verification Checklist
- Verify the Company's ability to meet the $221.25 million trailing twelve-month revenue target by September 30, 2019, to unlock Tranche 2 funding.
- Confirm the Company's current liquidity position against the covenant requirement of the greater of 6 months burn or $10 million.
- Review the impact of the $17.65 million lease termination payment on immediate cash flow.
- Assess the implications of the 6.25% final payment fee on the total cost of debt over the life of the loan.
- Monitor the status of the new lease agreements required to be executed by December 31, 2019.